Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor update to the page's versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe revision is updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 and removed the government-funding operating-status notice and prior revision (v3.4.1); these are administrative site updates that do not alter study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedNotice about lapse in government funding added and page revision updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.